News about "Lupin Limited partners with Spektus Pharma"

Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada

Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada

Lupin Limited has signed a licence and supply agreement with Spektus Pharma to commercialize DeslaFlex, a novel antidepressant, in Canada.

Lupin Limited Partners With Spektus Pharma | 16/02/2026 | By Darshana 103


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members